News Industry News Study From China Examines Clinical Outcomes Of Two Drug-Eluting Stents With Bioresorbable Polymers Employing Different Elution And Absorption Rates October 14, 2015
News Industry News Randomized Trial Of Diabetic Patients In India Finds Paclitaxel-Eluting Stents Failed To Meet Non-Inferiority Compared To Everolimus-Eluting Stents October 14, 2015
News Industry News Polymer-Free Drug-Coated vs. Bare-Metal Coronary Stents In High Bleeding Risk Patients With One Month DAPT October 14, 2015
News Industry News Plaque Modification With Scoring Balloon Improves Angiographic Outcomes In Patients Treated With A Drug-Coated Balloon For Drug-Eluting Stent Restenosis October 14, 2015
News Industry News Drug-Coated Balloon Shown To Be Superior To Conventional Angioplasty In Treating Superficial Femoral Artery Disease After Two Years October 14, 2015
Presentation TCT 2015 Together Were better. On Engagement, Empowerment, and Autonomy Presenter: Aaron V. Kaplan, Hugo Campos October 13, 2015
Presentation TCT 2015 The Conundrum of Cost-effective but Unaffordable Care: The Plight of High-Tech New Interventional Therapies Presenter: Aaron V. Kaplan, David J. Cohen October 13, 2015
Presentation TCT 2015 The Evolving CMS Reimbursement Process: How Can CMS Promote Innovation, and What Clinical Data Make a Difference? Presenter: Aaron V. Kaplan, James Rollins October 13, 2015
Presentation TCT 2015 Anticipated Changes in the European Regulatory Landscape: Impact on Device Development and Innovation Presenter: Aaron V. Kaplan, Angeles Alonso Garcia October 13, 2015
Presentation TCT 2015 Big Data: Opportunities and Challenges 4 Academia Perspectives Presenter: Roxana Mehran, Laura Mauri October 13, 2015
Presentation TCT 2015 Big Data: Opportunities and Challenges 3 Industry Perspectives Presenter: Roxana Mehran, Keith D. Dawkins October 13, 2015
Presentation TCT 2015 Big Data: Opportunities and Challenges 2 EMA Perspectives Presenter: Roxana Mehran, Angeles Alonso Garcia October 13, 2015
Presentation TCT 2015 Big Data: Opportunities and Challenges 1 FDA Perspectives Presenter: Roxana Mehran, John C Laschinger October 13, 2015
Presentation TCT 2015 Is the Answer Pragmatic/Simple Trials? Are They Really So Simple? Presenter: Roxana Mehran, Robert A. Harrington October 13, 2015
Presentation TCT 2015 TCT 48: Early Vascular Responses to Everolimus-Eluting Cobalt-Chromium Stent for the Treatment of Stable Coronary Artery Disease The Results of MECHANISM Elective 1-Month OCT Follow-up Cohort Presenter: Stephan Achenbach, Marc D. Feldman, Toshiro Shinke October 13, 2015
Presentation TCT 2015 A White Paper From EFS Physician Enthusiasts: Honest Appraisals and Lessons Learned Presenter: Andrew Farb, Michael J. Mack October 13, 2015
Presentation TCT 2015 The Early Feasibility Study (EFS) Program: First-Term Report Card Presenter: Andrew Farb, Michael J. Mack October 13, 2015
Presentation TCT 2015 TCT 46: OCT-Based Management of Late-Stent Thrombosis Results From the SAFE Registry Presenter: Stephan Achenbach, Marc D. Feldman, Catalin Toma October 13, 2015
Presentation TCT 2015 Keynote Lecture 1: A Revitalization Plan for the FDA-CDRH Emphasis on Policy Changes, Innovation, and Technology Presenter: Gregg W. Stone, Bram D. Zuckerman, Jeffrey Shuren October 13, 2015